Clinical trial
Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System - US
NCT03056534 is registered in ClinicalTrials.gov with Smith & Nephew, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System - US
- Lead sponsor
- Smith & Nephew, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 7, 2018
- Completion date
- May 31, 2023
- Enrollment
- 189 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative joint disease